Clinical Trial Update: Epicutaneous Immunotherapy in Peanut Allergy in Children [Phase 2]

View source ↗

Summary

Phase 2 trial update on epicutaneous immunotherapy for peanut allergy in children; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peanut Allergy

Drugs mentioned

• Epicutaneous immunotherapy patch for peanut allergy (epicutaneous immunotherapy)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Peanut Allergy | Phase 2 | Status: COMPLETED